{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:05:56Z","timestamp":1790694356000,"version":"4.1.0"},"reference-count":31,"publisher":"Japan Atherosclerosis Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Atheroscler Thromb","JAT"],"published-print":{"date-parts":[[2018]]},"DOI":"10.5551\/jat.40170","type":"journal-article","created":{"date-parts":[[2017,6,30]],"date-time":"2017-06-30T22:05:52Z","timestamp":1498860352000},"page":"170-177","source":"Crossref","is-referenced-by-count":13,"title":["Newly Developed Rat Model of Chronic Kidney Disease\u2013Mineral Bone Disorder"],"prefix":"10.5551","volume":"25","author":[{"given":"Kentaro","family":"Watanabe","sequence":"first","affiliation":[{"name":"Division of Nephrology and Kidney Center, Kobe University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Fujii","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Kidney Center, Kobe University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Goto","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Kidney Center, Kobe University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Nakai","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Kidney Center, Kobe University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Kono","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Kidney Center, Kobe University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Kidney Center, Kobe University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Shinohara","sequence":"additional","affiliation":[{"name":"Plannning and Development Section, CLEA Japan, Inc."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Nishi","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Kidney Center, Kobe University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Moe S, Dr\u00fceke T, Cunningham J, Goodman W, Martin K, Olgaard K, Ott S, Sprague S, Lameire N, and Eknoyan G: Kidney Disease: Improving Global Outcomes (KDIGO): Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int, 2006; 69: 1945-1953","DOI":"10.1038\/sj.ki.5000414"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Russo D, Corrao S, Battaglia Y, Andreucci M, Caiazza A, Carlomagno A, Lamberti M, Pezone N, Pota A, Russo L, Sacco M, and Scognamiglio B: Progression of coronary artery calcification and cardiac events in patients with chronic renal disease not receiving dialysis. Kidney Int, 2011; 80: 112-118","DOI":"10.1038\/ki.2011.69"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Blacher J, Guerin AP, Pannier B, Marchais SJ, and London GM: Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension, 2001; 38: 938-942","DOI":"10.1161\/hy1001.096358"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Block GA, Raggi P, Bellasi A, Kooienga L, and Spiegel DM: Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int, 2007; 71: 438-441","DOI":"10.1038\/sj.ki.5002059"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Wang AY, Wang M, Woo J, Lam CW, Li PK, Lui SF, and Sanderson JE: Cardiac valve calcification as an important predictor for allcause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: A prospective study. J Am Soc Nephrol, 2003; 14: 159-168","DOI":"10.1097\/01.ASN.0000038685.95946.83"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Russo D, Corrao S, Battaglia Y, Andreucci M, Caiazza A, Carlomagno A, Lamberti M, Pezone N, Pota A, Russo L, Sacco M, and Scognamiglio B: Progression of coronary artery calcification and cardiac events in patients with chronic renal disease not receiving dialysis. Kidney Int, 2011; 80: 112-118","DOI":"10.1038\/ki.2011.69"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Nagpal S, Na S, and Rathnachalam R: Noncalcemic actions of vitamin D receptor ligands. Endocr Rev, 2005; 26: 662-687","DOI":"10.1210\/er.2004-0002"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Ravani P, Malberti F, Tripepi G, Pecchini P, Cutrupi S, Pizzini P, Mallamaci F, and Zoccali C; Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int, 2009; 75: 88-95","DOI":"10.1038\/ki.2008.501"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Tentori F, Hunt WC, Stidley CA, Rohrscheib MR, Bedrick EJ, Meyer KB, Johnson HK, and Zager PG: Medical Directors of Dialysis Clinic Inc. Mortality risk among hemodialysis patients receiving different vitamin D analogs. Kidney Int, 2006; 70: 1858-1865","DOI":"10.1038\/sj.ki.5001868"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Shoji T, Shinohara K, Kimoto E, Emoto M, Tahara H, Koyama H, Inaba M, Fukumoto S, Ishimura E, Miki T, Tabata T, and Nishizawa Y: Lower risk for cardiovascular mortality in oral1alpha-hydroxy vitamin D3 users in a haemodialysis population. Nephrol Dial Transplant, 2004; 19: 179-184","DOI":"10.1093\/ndt\/gfg513"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Teng M, Wolf M, Ofsthun MN, Lazarus JM, Hern\u00e1n MA, Camargo CA Jr, and Thadhani R: Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol, 2005; 16: 1115-1125","DOI":"10.1681\/ASN.2004070573"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Kovesdy CP, Ahmadzadeh S, Anderson JE, and Kalantar-Zadeh K: Association of activated vitamin D treatment and mortality in chronic kidney disease. Arch Intern Med, 2008; 168: 397-403","DOI":"10.1001\/archinternmed.2007.110"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Shoben AB, Rudser KD, de Boer IH, Young B, and Kestenbaum B: Association of oral calcitriol with improved survival in nondialyzed CKD. J Am Soc Nephrol 2008; 19: 1613-1619","DOI":"10.1681\/ASN.2007111164"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Rodriguez M, Martinez-Moreno JM, Rodr\u00edguez-Ortiz ME, Mu\u00f1oz-Casta\u00f1eda JR, and Almaden Y: Vitamin D and vascular calcification in chronic kidney disease. Kidney Blood Press Res, 2011; 34: 261-268","DOI":"10.1159\/000326903"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Fujii H, Hamada Y, and Fukagawa M: Bone formation in spontaneously diabetic Torii-newly established model of non-obese type 2 diabetes rats. Bone, 2008; 42: 372-379","DOI":"10.1016\/j.bone.2007.10.007"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Masuyama T, Komeda K, Hara A, Noda M, Shinohara M, Oikawa T, Kanazawa Y, and Taniguchi K: Biochem Biophys Res Commun, 2004; 314: 870-877","DOI":"10.1016\/j.bbrc.2003.12.180"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Shobeiri N, Adams MA, and Holden RM: Vascular calcification in animal models of CKD: A review. Am J Nephrol, 2010; 31: 471-481","DOI":"10.1159\/000299794"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Moe SM, Chen NX, Seifert MF, Sinders RM, Duan D, Chen X, Liang Y, Radcliff JS, White KE, and Gattone VH 2nd: A rat model of chronic kidney disease-mineral bone disorder. Kidney Int, 2009; 75: 176-184","DOI":"10.1038\/ki.2008.456"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Zittermann A, and Koerfer R: Protective and toxic effects of vitamin D on vascular calcification: clinical implications. Mol Aspects Med, 2008; 29: 423-432","DOI":"10.1016\/j.mam.2008.04.002"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Kono K, Fujii H, Nakai K, Goto S, Kitazawa R, Kitazawa S, Shinohara M, Hirata M, Fukagawa M, Nishi S: Antioxidative effect of vitamin D analog on incipient vascular lesion in non-obese type 2 diabetic rats. Am J Nephrol, 2013; 37: 167-174","DOI":"10.1159\/000346808"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Wang J, Wang F, Dong S, Zeng Q, Zhang L: Levels of Serum Phosphorus and Cardiovascular Surrogate Markers. J Atheroscler Thromb. 2016; 23: 95-104","DOI":"10.5551\/jat.31153"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Masumoto A, Sonou T, Ohya M, Yashiro M, Nakashima Y, Okuda K, Iwashita Y, Mima T, Negi S, Shigematsu T: Calcium Overload Accelerates Phosphate-Induced Vascular Calcification Via Pit-1, but not the Calcium-Sensing Receptor. J Atheroscler Thromb. 2017; in press","DOI":"10.5551\/jat.36574"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Torremad\u00e9 N, Bozic M, Panizo S, Barrio-Vazquez S, Fernandez-Mart\u00edn JL, Encinas M, Goltzman D, Arcidiacono MV, Fernandez E, and Valdivielso JM: Vascular Calcification Induced by Chronic Kidney Disease Is Mediated by an Increase of 1\u03b1-Hydroxylase Expression in Vascular Smooth Muscle Cells. J Bone Miner Res, 2016; 31: 1865-1876","DOI":"10.1002\/jbmr.2852"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Chang B, Schlussel Y, Sukumar D, Schneider SH, and Shapses SA: Influence of vitamin D and estrogen receptor gene polymorphisms on calcium absorption: BsmI predicts a greater decrease during energy restriction. Bone, 2015; 81: 138-144","DOI":"10.1016\/j.bone.2015.07.011"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Scialla JJ, Lau WL, Reilly MP, Isakova T, Yang HY, Crouthamel MH, Chavkin NW, Rahman M, Wahl P, Amaral AP, Hamano T, Master SR, Nessel L, Chai B, Xie D, Kallem RR, Chen J, Lash JP, Kusek JW, Budoff MJ, Giachelli CM, Wolf M, and Chronic Renal Insufficiency Cohort Study Investigators: Fibroblast growth factor 23 is not associated with and does not induce arterial calcification. Kidney Int, 2013; 83: 1159-1168","DOI":"10.1038\/ki.2013.3"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Desjardins L, Liabeuf S, Renard C, Lenglet A, Lemke HD, Choukroun G, Drueke TB, Massy ZA, and European Uremic Toxin (EUTox) Work Group: FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages. Osteoporos Int, 2012; 23: 2017-2025","DOI":"10.1007\/s00198-011-1838-0"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Scialla JJ, Lau WL, Reilly MP, Isakova T, Yang HY, Crouthamel MH, Chavkin NW, Rahman M, Wahl P, Amaral AP, Hamano T, Master SR, Nessel L, Chai B, Xie D, Kallem RR, Chen J, Lash JP, Kusek JW, Budoff MJ, Giachelli CM, Wolf M, and Chronic Renal Insufficiency Cohort Study Investigators: Fibroblast growth factor 23 is not associated with and does not induce arterial calcification. Kidney Int, 2013; 83: 1159-1168","DOI":"10.1038\/ki.2013.3"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T, Fukumoto S, Tomizuka K, and Yamashita T: Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest, 2004; 113: 561-568","DOI":"10.1172\/JCI19081"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Mattinzoli D, Rastaldi MP, Ikehata M, Armelloni S, Pignatari C, Giardino LA, Li M, Alfieri CM, Regalia A, Riccardi D, and Messa P: FGF23-regulated production of Fetuin-A (AHSG) in osteocytes. Bone, 2016; 83: 35-47","DOI":"10.1016\/j.bone.2015.10.008"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Jimbo R, Kawakami-Mori F, Mu S, Hirohama D, Majtan B, Shimizu Y, Yatomi Y, Fukumoto S, Fujita T, and Shimosawa T: Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency. Kidney Int, 2014; 85: 1103-1111","DOI":"10.1038\/ki.2013.332"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Silver J, and Naveh-Many T: FGF-23 and secondary hyperparathyroidism in chronic kidney disease. Nat Rev Nephrol, 2013; 9: 641-664","DOI":"10.1038\/nrneph.2013.147"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/25\/2\/25_40170\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,28]],"date-time":"2019-09-28T02:27:15Z","timestamp":1569637635000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/25\/2\/25_40170\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.40170","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}